603041.SH
美思德
SSE · Basic Materials · Chemicals - Specialty · CN
CNY 10.93
−1.89%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 642.0M | 618.1M | 601.2M | 501.0M | 496.8M |
| Cost of Revenue | 498.7M | 483.1M | 427.3M | 308.9M | 359.7M |
| Gross Profit | 143.4M | 135.0M | 173.9M | 192.1M | 137.1M |
| Operating Expenses | |||||
| R&D Expense | 32.6M | 33.6M | 35.9M | 29.6M | 26.0M |
| SG&A Expense | — | — | — | — | — |
| General & Admin Expense | 29.5M | 28.9M | 32.0M | 29.2M | 18.2M |
| Selling & Marketing Expense | 17.2M | 20.0M | 22.7M | 25.6M | 21.2M |
| Other Expenses | — | — | — | — | — |
| Total Operating Expenses | 86.6M | 84.5M | 91.7M | 79.1M | 52.9M |
| Cost and Expenses | 585.3M | 567.5M | 519.0M | 388.1M | 412.6M |
| Operating Income (EBIT) | 77.3M | 75.2M | 76.5M | 128.4M | 89.5M |
| Non-Operating | |||||
| Interest Income | — | — | — | — | — |
| Interest Expense | — | — | — | — | — |
| Net Interest Income | — | — | — | — | — |
| Other Non-Op Income/Expense | — | — | — | — | — |
| Non-Operating Income (excl Interest) | — | — | — | — | — |
| EBT (Pre-Tax Income) | 77.4M | 75.4M | 76.6M | 128.8M | 89.5M |
| Income Tax Expense | 18.6M | 20.5M | 18.2M | 19.0M | 10.5M |
| Bottom Line | |||||
| Net Income | 58.8M | 56.7M | 64.1M | 110.0M | 78.9M |
| Earnings from Cont. Ops | 58.8M | 54.9M | 58.4M | 109.8M | 78.9M |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 58.8M | 56.7M | 64.1M | 110.0M | 78.9M |
| Per Share | |||||
| Basic EPS | CN¥0.33 | CN¥0.31 | CN¥0.35 | CN¥0.61 | CN¥0.47 |
| Diluted EPS | CN¥0.33 | CN¥0.31 | CN¥0.35 | CN¥0.61 | CN¥0.47 |
| Revenue Per Share | CN¥3.60 | CN¥3.38 | CN¥3.28 | CN¥2.78 | CN¥2.96 |
| Shares | |||||
| Basic Shares Outstanding | 178.1M | 182.8M | 183.3M | 180.3M | 167.9M |
| Diluted Shares Outstanding | 178.1M | 182.8M | 183.3M | 180.3M | 167.9M |
| Profitability Metrics | |||||
| EBITDA | — | 130.5M | 132.3M | 147.3M | 107.3M |
| D&A | — | 55.2M | 55.8M | 18.9M | 17.9M |
| EBIT | — | — | — | — | — |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026